ABL1 and acute lymphoblastic leukemia: Recent development of novel “chemotherapy-free” regimens combining BCR-ABL TKI with steroids and immunotherapy for older Ph+ALL may also be particularly relevant for treatment of individuals adhering to the JW faith [3].